Pioglitazone ameliorates sepsis-associated encephalopathy through SIRT1 signaling pathway
International Immunopharmacology · 2024-09 · 139 · 112757
DOI: 10.1016/j.intimp.2024.112757 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-09. Verfasst von Alaa H Shehata und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Minia, Egypt. Hauptthemen laut MEDLINE: Sirtuin 1, Pioglitazone, Sepsis-Associated Encephalopathy, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: Minia University.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a severe immune response to an infection. It is associated with multiple organ dysfunction syndrome (MODs) along with systemic and neuronal inflammatory response. This study focused on the acute neurologic dysfunction associated with sepsis by exploring the role of PPARγ/SIRT1 pathway against sepsis. We studied the role of this axis in ameliorating sepsis-associated encephalopathy (SAE) and its linked neurobehavioral disorders by using pioglitazone (PIO). This PPARγ agonist showed neuroprotective actions in neuroinflammatory disorders. Sepsis was induced in mice by LPS (10 mg/kg). Survival rate and MODs were assessed. Furthermore, behavioral deficits, cerebral oxidative, inflammatory, and apoptotic markers, and the cerebral expression level of SIRT1 were determined. In this study, we observed that PIO attenuated sepsis-induced cerebral injury. PIO significantly enhanced survival rate, attenuated MODs, and systemic inflammatory response in septic mice. PIO also promoted cerebral SIRT1 expression and reduced cerebral activation of microglia, oxidative stress, HMGB, iNOS, NLRP3 and caspase-3 along with an obvious improvement in behavioral deficits and cerebral pathological damage induced by LPS. Most of the neuroprotective effects of PIO were abolished by EX-527, a SIRT1 inhibitor. These results highlight that the neuroprotective effect of PIO in SAE is mainly SIRT1-dependent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Minia, Egypt.
- Department of Histology and Cell Biology, Faculty of Medicine, Minia University, Minia, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt; Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.
- Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, USA; Department of Clinical Pharmacy, Faculty of Pharmacy, Minia University, Minia, Egypt.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Minia, Egypt. Electronic address: Shaimaa.faissal@minia.edu.eg.
Förderung
- Minia University
Zitieren
APA
Shehata, A. H., Anter, A. F., Mohamed Naguib Abdel Hafez, S., Rn Ibrahim, A., Kamel, E. S., & Ahmed, A. F. (2024). Pioglitazone ameliorates sepsis-associated encephalopathy through SIRT1 signaling pathway. International Immunopharmacology, 139, 112757. https://doi.org/10.1016/j.intimp.2024.112757
Vancouver
Shehata AH, Anter AF, Mohamed Naguib Abdel Hafez S, Rn Ibrahim A, Kamel ES, Ahmed AF. Pioglitazone ameliorates sepsis-associated encephalopathy through SIRT1 signaling pathway. International Immunopharmacology. 2024;139:112757. doi:10.1016/j.intimp.2024.112757
BibTeX
@article{Shehata2024,
author = {Shehata, Alaa H and Anter, Aliaa F and Mohamed Naguib Abdel Hafez, Sara and Rn Ibrahim, Ahmed and Kamel, Eman S and Ahmed, Al-Shaimaa F},
title = {Pioglitazone ameliorates sepsis-associated encephalopathy through SIRT1 signaling pathway},
journal = {International Immunopharmacology},
year = {2024},
volume = {139},
pages = {112757},
doi = {10.1016/j.intimp.2024.112757}
}
EUVIMED